Project Grant R41NS132734
Award Date
9/15/23
Completion Date
8/31/24
Dollars Obligated
$495K
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Renerva LLC (LJ97PLMMTGV1)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Pensilvania, EE. UU.
Similar Awards
This $999,998 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports the development of Renerva LLC's Peripheral Nerve Matrix (PNM) technology. PNM is a tissue-based hydrogel derived from porcine nerve that aims to improve functional outcomes for patients with challenging peripheral nerve gap injuries. The Phase I project will optimize the PNM...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $296,151 to Insoma Bio, Inc. to investigate the use of their proprietary Fractomer biomaterial to improve outcomes after peripheral nerve repair. The project aims to demonstrate that Fractomer, an injectable polypeptide scaffold, can provide the necessary mechanical support and...
The University of Nebraska Medical Center (UNMC) was awarded a $437,331 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will support the development of a novel "optoelectronically active nerve adhesive" to accelerate peripheral nerve repair and regeneration. Specifically, the project aims to incorporate innovative...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders", provides $594,115.00 to the University of Utah to conduct research on the pathophysiology of peripheral nerve regeneration and the formation of neuromas. The key objectives of this 5-year project are to: 1) analyze the cellular composition, activation states, and spatial niches involved in...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA Program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, is focused on developing a noninvasive, nanoparticle-directed therapy to deliver treatments to the peripheral nervous system. The $310,834 award to Clemson University supports research to design and implement a nerve-targeting polymersome platform that can penetrate the blood-nerve barrier and...
This Project Grant award of $1,214,399 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will fund the development of a novel minimally invasive electrode strategy to better target the posterior tibial nerve for the treatment of overactive bladder (OAB). The University of Wisconsin System is the prime awardee, with subawards to Neuronoff Inc. for device fabrication and Case...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $5,666,172 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University (NYU) to conduct research on targeting Schwann cell dysfunction and repair signaling in chemotherapy-induced painful peripheral neuropathy (CIPPN). The research aims to study the role of the peroxisome proliferator activated receptor gamma (PPARG) and low-density lipoprotein receptor related protein 1 (LRP1)...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on developing a novel drug candidate to treat demyelinating neuropathies. The $352,073 award will support rigorous in vivo testing of the experimental ABCA1 agonist drug, CS6253, in validated mouse models of hereditary peripheral nerve disorders characterized by impaired...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $638,718 project grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to The Feinstein Institutes For Medical Research to conduct research on "Selective, Epineural Stimulation of Peripheral Nerves with Interferential Electrical Fields". The primary objectives are to: 1) Test the hypothesis that interferential current stimulation can selectively activate specific...
The National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $970,052 Project Grant to Backstop Neural, Inc. on Aug 20, 2024. The goal of this Phase I SBIR project is to demonstrate the feasibility of a novel, thin and softening epidural stimulation lead to treat chronic arm and neck pain. The key products to be delivered include: 1) Design and fabrication of a 16-channel, 0.2 mm thick human-sized softening...